[Therapy of liver diseases, possibilities and problems].
D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D004035:Diet Therapy; D004790:Enzyme Induction; D005260:Female; D006505:Hepatitis / Q000188:drug therapy; D006506:Hepatitis A / Q000517:prevention & control; D006509:Hepatitis B / Q000517:prevention & control; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007231:Infant, Newborn; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D008110:Liver Extracts / Q000627:therapeutic use; D008297:Male; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D012146:Rest; D005719:gamma-Globulins / Q000627:therapeutic use
D045930:Anabolic Agents; D008110:Liver Extracts; D005719:gamma-Globulins; D002792:Cholestyramine Resin; D011241:Prednisone
Therapie der Leberkrankheiten, Möglichkeiten und Probleme.